Clinical Trial Update: TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223) [Phase 4]

View source ↗

Summary

Pfizer reports completion of a Phase 4 follow-up study evaluating antibody persistence and booster vaccination for tick-borne encephalitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Snippet

Sponsor: Pfizer | Conditions: Encephalitis, Tick-Borne | Phase 4 | Status: COMPLETED